Oncotech Ltd develops AI‑powered, on‑demand cancer (and diabetes) screening technology and novel ant Sign up to read more
No share issues or funding rounds.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| MARAT KALIMULOV | ORD | 336,237 | 32.4% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity ONCOTECH LTD raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
| 88888888 |
| 888888 |
| 8888 |
17 more shareholders on file , sign up free to see.